{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:10:19Z","timestamp":1792613419616,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Colistin is a polymyxin antibiotic which has been used for treatment of Gram-negative infections, but it was withdrawn due to its nephrotoxicity. However, colistin has gained its popularity in recent years due to the reemergence of multidrug resistant Gram-negative infections and drug-induced toxicity is considered as the main obstacle for using this valuable antibiotic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 30 articles, including 29 animal studies and one clinical trial were included in this study. These compounds, including aged black garlic extract, albumin fragments, alpha lipoic acid, astaxanthin, baicalein, chrysin, cilastatin, colchicine, curcumin, cytochrome c, dexmedetomidine, gelofusine, grape seed proanthocyanidin extract, hesperidin, luteolin, lycopene, melatonin, methionine, N-acetylcysteine, silymarin, taurine, vitamin C, and vitamin E exhibited beneficial effects in most of the published works.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this review, the authors have attempted to review the available literature on the use of several compounds for prevention or attenuation of colistin-induced nephrotoxicity. Most of the studied compounds were potent antioxidants, and it seems that using antioxidants concomitantly can have a protective effect during the colistin exposure.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40001-022-00689-w","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T13:02:37Z","timestamp":1651928557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Pharmacological agents for the prevention of colistin-induced nephrotoxicity"],"prefix":"10.1186","volume":"27","author":[{"given":"Mahtabalsadat","family":"Mirjalili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Vazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"issue":"9","key":"689_CR1","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1086\/429323","volume":"40","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333\u201341.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"689_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","volume":"22","author":"RL Nation","year":"2009","unstructured":"Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009;22(6):535\u201343.","journal-title":"Curr Opin Infect Dis"},{"issue":"9","key":"689_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","volume":"6","author":"J Li","year":"2006","unstructured":"Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589\u2013601.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"689_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","volume":"30","author":"LM Lim","year":"2010","unstructured":"Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd, et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy. 2010;30(12):1279\u201391.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"689_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.ijantimicag.2005.09.004","volume":"26","author":"ME Falagas","year":"2005","unstructured":"Falagas ME, Fragoulis KN, Kasiakou SK, Sermaidis GJ, Michalopoulos A. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int J Antimicrob Agents. 2005;26(6):504\u20137.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"689_CR6","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00228-015-1865-4","volume":"71","author":"A Ordooei Javan","year":"2015","unstructured":"Ordooei Javan A, Shokouhi S, Sahraei Z. A review on colistin nephrotoxicity. Eur J Clin Pharmacol. 2015;71(7):801\u201310.","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"689_CR7","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3855\/jidc.9443","volume":"11","author":"A Ciftci","year":"2018","unstructured":"Ciftci A, Izdes S, Altintas ND. Factors determining nephrotoxicity and mortality in critical care patients receiving colistin. J Infect Dev Ctries. 2018;11(12):912\u20138.","journal-title":"J Infect Dev Ctries"},{"issue":"8","key":"689_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s10096-019-03546-7","volume":"38","author":"C Heybeli","year":"2019","unstructured":"Heybeli C, Oktan MA, \u00c7avdar Z. Rat models of colistin nephrotoxicity: previous experimental researches and future perspectives. Eur J Clin Microbiol Infect Dis. 2019;38(8):1387\u201393.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"689_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02319-16","author":"AP Zavascki","year":"2017","unstructured":"Zavascki AP, Nation RL. Nephrotoxicity of polymyxins: is there any difference between colistimethate and polymyxin B? Antimicrob Agents Chemother. 2017. https:\/\/doi.org\/10.1128\/AAC.02319-16.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"689_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41598-020-78098-4","volume":"11","author":"W Katip","year":"2021","unstructured":"Katip W, Yoodee J, Uitrakul S, Oberdorfer P. Efficacy of loading dose colistin versus carbapenems for treatment of extended spectrum beta lactamase producing Enterobacteriaceae. Sci Rep. 2021;11(1):18.","journal-title":"Sci Rep"},{"key":"689_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2147\/IDR.S144314","volume":"10","author":"W Katip","year":"2017","unstructured":"Katip W, Uitrakul S, Oberdorfer P. Clinical outcomes and nephrotoxicity of colistin loading dose for treatment of extensively drug-resistant Acinetobacter baumannii in cancer patients. Infect Drug Resist. 2017;10:293\u20138.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"689_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/pharmaceutics14010031","volume":"14","author":"W Katip","year":"2021","unstructured":"Katip W, Uitrakul S, Oberdorfer P. Clinical efficacy and nephrotoxicity of the loading dose colistin for the treatment of carbapenem-resistant Acinetobacter baumannii in critically ill patients. Pharmaceutics. 2021;14(1):31.","journal-title":"Pharmaceutics"},{"issue":"1","key":"689_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/0886022X.2020.1795878","volume":"42","author":"E Gunay","year":"2020","unstructured":"Gunay E, Kaya S, Baysal B, Yuksel E, Arac E. Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit. Ren Fail. 2020;42(1):704\u20139.","journal-title":"Ren Fail"},{"issue":"3","key":"689_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/molecules24030653","volume":"24","author":"Z Gai","year":"2019","unstructured":"Gai Z, Samodelov SL, Kullak-Ublick GA, Visentin M. Molecular mechanisms of colistin-induced nephrotoxicity. Molecules (Basel, Switzerland). 2019;24(3):653.","journal-title":"Molecules (Basel, Switzerland)."},{"key":"689_CR15","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.clnesp.2017.11.010","volume":"24","author":"C Xu","year":"2018","unstructured":"Xu C, Mathews AE, Rodrigues C, Eudy BJ, Rowe CA, O\u2019Donoughue A, et al. Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr ESPEN. 2018;24:148\u201355.","journal-title":"Clin Nutr ESPEN"},{"issue":"3s","key":"689_CR16","doi-asserted-by":"publisher","first-page":"1080s","DOI":"10.1093\/jn\/131.3.1080S","volume":"131","author":"S Kasuga","year":"2001","unstructured":"Kasuga S, Uda N, Kyo E, Ushijima M, Morihara N, Itakura Y. Pharmacologic activities of aged garlic extract in comparison with other garlic preparations. J Nutr. 2001;131(3s):1080s-s1084.","journal-title":"J Nutr"},{"issue":"3s","key":"689_CR17","doi-asserted-by":"publisher","first-page":"1010s","DOI":"10.1093\/jn\/131.3.1010S","volume":"131","author":"C Borek","year":"2001","unstructured":"Borek C. Antioxidant health effects of aged garlic extract. J Nutr. 2001;131(3s):1010s-s1015.","journal-title":"J Nutr"},{"issue":"1","key":"689_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4103\/0253-7613.106429","volume":"45","author":"TM Shiju","year":"2013","unstructured":"Shiju TM, Rajesh NG, Viswanathan P. Renoprotective effect of aged garlic extract in streptozotocin-induced diabetic rats. Indian J Pharmacol. 2013;45(1):18\u201323.","journal-title":"Indian J Pharmacol"},{"issue":"1","key":"689_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12935-014-0092-x","volume":"14","author":"AY Nasr","year":"2014","unstructured":"Nasr AY, Saleh HA. Aged garlic extract protects against oxidative stress and renal changes in cisplatin-treated adult male rats. Cancer Cell Int. 2014;14(1):92.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"689_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/0886022X.2018.1561375","volume":"41","author":"TW Lee","year":"2019","unstructured":"Lee TW, Bae E, Kim JH, Jang HN, Cho HS, Chang SH, et al. The aqueous extract of aged black garlic ameliorates colistin-induced acute kidney injury in rats. Ren Fail. 2019;41(1):24\u201333.","journal-title":"Ren Fail"},{"issue":"4","key":"689_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrm778","volume":"3","author":"EI Christensen","year":"2002","unstructured":"Christensen EI, Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol. 2002;3(4):256\u201366.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"689_CR22","first-page":"223","volume":"27","author":"EI Christensen","year":"2012","unstructured":"Christensen EI, Birn H, Storm T, Weyer K, Nielsen R. Endocytic receptors in the renal proximal tubule. Physiology (Bethesda). 2012;27(4):223\u201336.","journal-title":"Physiology (Bethesda)"},{"issue":"6","key":"689_CR23","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1681\/ASN.2016060606","volume":"28","author":"Y Hori","year":"2017","unstructured":"Hori Y, Aoki N, Kuwahara S, Hosojima M, Kaseda R, Goto S, et al. Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J Am Soc Nephrol. 2017;28(6):1783\u201391.","journal-title":"J Am Soc Nephrol"},{"issue":"4 Pt 2","key":"689_CR24","first-page":"F900","volume":"271","author":"S Cui","year":"1996","unstructured":"Cui S, Verroust PJ, Moestrup SK, Christensen EI. Megalin\/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol. 1996;271(4 Pt 2):F900\u20137.","journal-title":"Am J Physiol"},{"issue":"9","key":"689_CR25","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.2967\/jnumed.108.053249","volume":"49","author":"E Vegt","year":"2008","unstructured":"Vegt E, van Eerd JE, Eek A, Oyen WJ, Wetzels JF, de Jong M, et al. Reducing renal uptake of radiolabeled peptides using albumin fragments. J Nucl Med. 2008;49(9):1506\u201311.","journal-title":"J Nucl Med"},{"issue":"12","key":"689_CR26","doi-asserted-by":"publisher","first-page":"6319","DOI":"10.1128\/AAC.00254-13","volume":"57","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Yamaguchi H, Ogura J, Kobayashi M, Yamada T, Iseki K. Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother. 2013;57(12):6319\u201324.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"689_CR27","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/biom9080356","volume":"9","author":"B Salehi","year":"2019","unstructured":"Salehi B, Berkay Y\u0131lmaz Y, Antika G, Boyunegmez Tumer T, Fawzi Mahomoodally M, Lobine D, et al. Insights on the use of \u03b1-lipoic acid for therapeutic purposes. Biomolecules. 2019;9(8):356.","journal-title":"Biomolecules"},{"issue":"5","key":"689_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1034\/j.1600-0773.2000.d01-41.x","volume":"86","author":"SM Somani","year":"2000","unstructured":"Somani SM, Husain K, Whitworth C, Trammell GL, Malafa M, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol. 2000;86(5):234\u201341.","journal-title":"Pharmacol Toxicol"},{"issue":"5","key":"689_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1081\/JDI-200031761","volume":"26","author":"P Murugavel","year":"2004","unstructured":"Murugavel P, Pari L. Attenuation of chloroquine-induced renal damage by alpha-lipoic acid: possible antioxidant mechanism. Ren Fail. 2004;26(5):517\u201324.","journal-title":"Ren Fail"},{"issue":"10","key":"689_CR30","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/ndt\/gfp242","volume":"24","author":"KP Kang","year":"2009","unstructured":"Kang KP, Kim DH, Jung YJ, Lee AS, Lee S, Lee SY, et al. Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. Nephrol Dial Transplant. 2009;24(10):3012\u201320.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"689_CR31","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1159\/000235754","volume":"113","author":"YM Lee","year":"2009","unstructured":"Lee YM, Bae SY, Won NH, Pyo HJ, Kwon YJ. Alpha-lipoic acid attenuates cisplatin-induced tubulointerstitial injuries through inhibition of mitochondrial bax translocation in rats. Nephron Exp Nephrol. 2009;113(4):e104\u201312.","journal-title":"Nephron Exp Nephrol"},{"issue":"2","key":"689_CR32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s12011-019-01733-3","volume":"193","author":"Z Cavdar","year":"2020","unstructured":"Cavdar Z, Oktan MA, Ural C, Calisir M, Kocak A, Heybeli C, et al. Renoprotective effects of alpha lipoic acid on iron overload-induced kidney injury in rats by suppressing NADPH oxidase 4 and p38 MAPK signaling. Biol Trace Elem Res. 2020;193(2):483\u201393.","journal-title":"Biol Trace Elem Res"},{"issue":"11","key":"689_CR33","first-page":"2132","volume":"19","author":"T \u00c7ak\u0131r","year":"2015","unstructured":"\u00c7ak\u0131r T, Polat C, Ba\u015ft\u00fcrk A, G\u00fcl M, Aslaner A, Durgut H, et al. The effect of alpha lipoic acid on rat kidneys in methotrexate induced oxidative injury. Eur Rev Med Pharmacol Sci. 2015;19(11):2132\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"689_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000448666","volume":"134","author":"J Zhang","year":"2016","unstructured":"Zhang J, McCullough PA. Lipoic acid in the prevention of acute kidney injury. Nephron. 2016;134(3):133\u201340.","journal-title":"Nephron"},{"issue":"5","key":"689_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0960327120966043","volume":"40","author":"MA Oktan","year":"2021","unstructured":"Oktan MA, Heybeli C, Ural C, Kocak A, Bilici G, Cavdar Z, et al. Alpha-lipoic acid alleviates colistin nephrotoxicity in rats. Hum Exp Toxicol. 2021;40(5):761\u201371.","journal-title":"Hum Exp Toxicol"},{"issue":"22","key":"689_CR36","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.3390\/molecules25225342","volume":"25","author":"MX Chang","year":"2020","unstructured":"Chang MX, Xiong F. Astaxanthin and its effects in inflammatory responses and inflammation-associated diseases: recent advances and future directions. Molecules. 2020;25(22):5342.","journal-title":"Molecules"},{"issue":"1","key":"689_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mnfr.201000414","volume":"55","author":"JP Yuan","year":"2011","unstructured":"Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol Nutr Food Res. 2011;55(1):150\u201365.","journal-title":"Mol Nutr Food Res"},{"issue":"8","key":"689_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3390\/md16080247","volume":"16","author":"C Galasso","year":"2018","unstructured":"Galasso C, Orefice I, Pellone P, Cirino P, Miele R, Ianora A, et al. On the neuroprotective role of astaxanthin: new perspectives? Mar Drugs. 2018;16(8):247.","journal-title":"Mar Drugs"},{"issue":"4","key":"689_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/nu10040522","volume":"10","author":"S Davinelli","year":"2018","unstructured":"Davinelli S, Nielsen ME, Scapagnini G. Astaxanthin in skin health, repair, and disease: a comprehensive review. Nutrients. 2018;10(4):522.","journal-title":"Nutrients"},{"issue":"1","key":"689_CR40","first-page":"27","volume":"22","author":"M Kurashige","year":"1990","unstructured":"Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol Chem Phys Med NMR. 1990;22(1):27\u201338.","journal-title":"Physiol Chem Phys Med NMR"},{"issue":"1","key":"689_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/biof.5520200105","volume":"20","author":"Y Naito","year":"2004","unstructured":"Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, et al. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db\/db mice. BioFactors (Oxford, England). 2004;20(1):49\u201359.","journal-title":"BioFactors (Oxford, England)"},{"issue":"1","key":"689_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.fct.2007.08.001","volume":"46","author":"PR Augusti","year":"2008","unstructured":"Augusti PR, Conterato GM, Somacal S, Sobieski R, Spohr PR, Torres JV, et al. Effect of astaxanthin on kidney function impairment and oxidative stress induced by mercuric chloride in rats. Food Chem Toxicol. 2008;46(1):212\u20139.","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"689_CR43","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.etap.2014.03.004","volume":"37","author":"Z Ghlissi","year":"2014","unstructured":"Ghlissi Z, Hakim A, Sila A, Mnif H, Zeghal K, Rebai T, et al. Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model. Environ Toxicol Pharmacol. 2014;37(3):960\u20136.","journal-title":"Environ Toxicol Pharmacol"},{"key":"689_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.phrs.2015.08.021","volume":"100","author":"MR de Oliveira","year":"2015","unstructured":"de Oliveira MR, Nabavi SF, Habtemariam S, Erdogan Orhan I, Daglia M, Nabavi SM. The effects of baicalein and baicalin on mitochondrial function and dynamics: a review. Pharmacol Res. 2015;100:296\u2013308.","journal-title":"Pharmacol Res"},{"key":"689_CR45","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.3389\/fphar.2019.01466","volume":"10","author":"S Liang","year":"2019","unstructured":"Liang S, Deng X, Lei L, Zheng Y, Ai J, Chen L, et al. The Comparative study of the therapeutic effects and mechanism of baicalin, baicalein, and their combination on ulcerative colitis rat. Front Pharmacol. 2019;10:1466.","journal-title":"Front Pharmacol"},{"issue":"10","key":"689_CR46","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/ijms17101681","volume":"17","author":"H Liu","year":"2016","unstructured":"Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng P, et al. The Fascinating effects of baicalein on cancer: a review. Int J Mol Sci. 2016;17(10):1681.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"689_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134139","volume":"10","author":"BD Sahu","year":"2015","unstructured":"Sahu BD, Mahesh Kumar J, Sistla R. Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-\u03baB pathways. PLoS ONE. 2015;10(7): e0134139-e.","journal-title":"PLoS ONE"},{"issue":"3","key":"689_CR48","first-page":"181","volume":"82","author":"CC Lai","year":"2016","unstructured":"Lai CC, Huang PH, Yang AH, Chiang SC, Tang CY, Tseng KW, et al. Baicalein, a component of Scutellaria baicalensis, attenuates kidney injury induced by myocardial ischemia and reperfusion. Planta Med. 2016;82(3):181\u20139.","journal-title":"Planta Med"},{"issue":"9","key":"689_CR49","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/jac\/dkx185","volume":"72","author":"C Dai","year":"2017","unstructured":"Dai C, Tang S, Wang Y, Velkov T, Xiao X. Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response. J Antimicrob Chemother. 2017;72(9):2562\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"689_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1871525717666190114145137","volume":"17","author":"T Farkhondeh","year":"2019","unstructured":"Farkhondeh T, Samarghandian S, Bafandeh F. The cardiovascular protective effects of chrysin: a narrative review on experimental researches. Cardiovasc Hematol Agents Med Chem. 2019;17(1):17\u201327.","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"issue":"5","key":"689_CR51","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0960-894X(02)01081-8","volume":"13","author":"X Zheng","year":"2003","unstructured":"Zheng X, Meng WD, Xu YY, Cao JG, Qing FL. Synthesis and anticancer effect of chrysin derivatives. Bioorg Med Chem Lett. 2003;13(5):881\u20134.","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"689_CR52","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S1043-6618(03)00248-2","volume":"49","author":"H Cho","year":"2004","unstructured":"Cho H, Yun CW, Park WK, Kong JY, Kim KS, Park Y, et al. Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives. Pharmacol Res. 2004;49(1):37\u201343.","journal-title":"Pharmacol Res"},{"issue":"11","key":"689_CR53","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/j.1440-1681.2004.04072.x","volume":"31","author":"OL Woodman","year":"2004","unstructured":"Woodman OL, Chan E. Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol. 2004;31(11):786\u201390.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"11","key":"689_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.21960","volume":"31","author":"E Eldutar","year":"2017","unstructured":"Eldutar E, Kandemir FM, Kucukler S, Caglayan C. Restorative effects of Chrysin pretreatment on oxidant-antioxidant status, inflammatory cytokine production, and apoptotic and autophagic markers in acute paracetamol-induced hepatotoxicity in rats: an experimental and biochemical study. J Biochem Mol Toxicol. 2017;31(11): e21960.","journal-title":"J Biochem Mol Toxicol"},{"key":"689_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejphar.2014.01.065","volume":"728","author":"EM Mantawy","year":"2014","unstructured":"Mantawy EM, El-Bakly WM, Esmat A, Badr AM, El-Demerdash E. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur J Pharmacol. 2014;728:107\u201318.","journal-title":"Eur J Pharmacol"},{"key":"689_CR56","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.biopha.2018.10.001","volume":"108","author":"B Hanedan","year":"2018","unstructured":"Hanedan B, Ozkaraca M, Kirbas A, Kandemir FM, Aktas MS, Kilic K, et al. Investigation of the effects of hesperidin and chrysin on renal injury induced by colistin in rats. Biomed Pharmacother. 2018;108:1607\u201316.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"689_CR57","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/14740338.2020.1796967","volume":"19","author":"M Shayan","year":"2020","unstructured":"Shayan M, Elyasi S. Cilastatin as a protective agent against drug-induced nephrotoxicity: a literature review. Expert Opin Drug Saf. 2020;19(8):999\u20131010.","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"689_CR58","first-page":"98","volume":"43","author":"J Smiechowicz","year":"2011","unstructured":"Smiechowicz J, Barteczko B, Grotowska M, Kaiser T, Zielinski S, Kubler A. Severe acute respiratory distress syndrome complicating type A (H1N1) influenza treated with extracorporeal CO2 removal. Anestezjol Intens Ter. 2011;43(2):98\u2013103.","journal-title":"Anestezjol Intens Ter"},{"issue":"12","key":"689_CR59","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00467-002-0956-5","volume":"17","author":"EI Christensen","year":"2002","unstructured":"Christensen EI, Verroust PJ. Megalin and cubilin, role in proximal tubule function and during development. Pediatr Nephrol. 2002;17(12):993\u20139.","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"689_CR60","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.3390\/molecules25194448","volume":"25","author":"A Vorobyeva","year":"2020","unstructured":"Vorobyeva A, Oroujeni M, Lindbo S, Hober S, Xu T, Liu Y, et al. Investigation of a pharmacological approach for reduction of renal uptake of radiolabeled ADAPT scaffold protein. Molecules. 2020;25(19):4448.","journal-title":"Molecules"},{"issue":"11","key":"689_CR61","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s00018-008-7452-4","volume":"65","author":"H Hatcher","year":"2008","unstructured":"Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631\u201352.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"689_CR62","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.redox.2013.09.003","volume":"1","author":"J Trujillo","year":"2013","unstructured":"Trujillo J, Chirino YI, Molina-Jij\u00f3n E, And\u00e9rica-Romero AC, Tapia E, Pedraza-Chaverr\u00ed J. Renoprotective effect of the antioxidant curcumin: Recent findings. Redox Biol. 2013;1(1):448\u201356.","journal-title":"Redox Biol"},{"key":"689_CR63","volume":"2013","author":"MA Morsy","year":"2013","unstructured":"Morsy MA, Ibrahim SA, Amin EF, Kamel MY, Rifaai RA, Hassan MK. Curcumin ameliorates methotrexate-induced nephrotoxicity in rats. Adv Pharmacol Sci. 2013;2013: 387071.","journal-title":"Adv Pharmacol Sci"},{"issue":"2","key":"689_CR64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/14740338.2020.1712357","volume":"19","author":"M Mahi-Birjand","year":"2020","unstructured":"Mahi-Birjand M, Yaghoubi S, Abdollahpour-Alitappeh M, Keshtkaran Z, Bagheri N, Pirouzi A, et al. Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: a systematic review. Expert Opin Drug Saf. 2020;19(2):167\u201386.","journal-title":"Expert Opin Drug Saf"},{"key":"689_CR65","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cbi.2018.08.012","volume":"294","author":"NE Edrees","year":"2018","unstructured":"Edrees NE, Galal AAA, Abdel Monaem AR, Beheiry RR, Metwally MMM. Curcumin alleviates colistin-induced nephrotoxicity and neurotoxicity in rats via attenuation of oxidative stress, inflammation and apoptosis. Chem Biol Interact. 2018;294:56\u201364.","journal-title":"Chem Biol Interact"},{"issue":"2","key":"689_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/0960327118783543","volume":"38","author":"ZD Li","year":"2019","unstructured":"Li ZD, Luo J, Jia LH, Wang XY, Xun ZK, Liu M. Cytochrome C suppresses renal accumulation and nephrotoxicity of polymyxin B. Hum Exp Toxicol. 2019;38(2):193\u2013200.","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"689_CR67","doi-asserted-by":"publisher","first-page":"1270021","DOI":"10.1080\/19932820.2017.1270021","volume":"12","author":"ME Erbatur","year":"2017","unstructured":"Erbatur ME, Sezen \u015eC, Bayraktar AC, Arslan M, Kavut\u00e7u M, Ayd\u0131n ME. Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats. Libyan J Med. 2017;12(1):1270021.","journal-title":"Libyan J Med"},{"issue":"1","key":"689_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/02656736.2018.1526416","volume":"36","author":"Y Song","year":"2019","unstructured":"Song Y, Kim DH, Kwon TD, Han DW, Baik SH, Jung HH, et al. Effect of intraoperative dexmedetomidine on renal function after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a randomized, placebo-controlled trial. Int J Hyperther. 2019;36(1):1\u20138.","journal-title":"Int J Hyperther"},{"issue":"3","key":"689_CR69","doi-asserted-by":"publisher","first-page":"R153","DOI":"10.1186\/cc10283","volume":"15","author":"J Gu","year":"2011","unstructured":"Gu J, Sun P, Zhao H, Watts HR, Sanders RD, Terrando N, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Critical Care (London, England). 2011;15(3):R153.","journal-title":"Critical Care (London, England)"},{"issue":"3","key":"689_CR70","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2015.306","volume":"89","author":"JS Cho","year":"2016","unstructured":"Cho JS, Shim JK, Soh S, Kim MK, Kwak YL. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89(3):693\u2013700.","journal-title":"Kidney Int"},{"issue":"4","key":"689_CR71","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.bjan.2018.01.017","volume":"68","author":"G Talih","year":"2018","unstructured":"Talih G, Esmao\u011flu A, Bayram A, Yazici C, Deniz K, Talih T. Does dexmedetomidine prevent colistin nephrotoxicity? Brazil J Anesthesiol. 2018;68(4):383\u20137.","journal-title":"Brazil J Anesthesiol"},{"issue":"2","key":"689_CR72","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s00259-009-1239-1","volume":"37","author":"E Vegt","year":"2010","unstructured":"Vegt E, Eek A, Oyen WJG, de Jong M, Gotthardt M, Boerman OC. Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides. Eur J Nucl Med Mol Imaging. 2010;37(2):226\u201334.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"689_CR73","first-page":"528","volume":"47","author":"JE van Eerd","year":"2006","unstructured":"van Eerd JE, Vegt E, Wetzels JF, Russel FG, Masereeuw R, Corstens FH, et al. Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. J Nucl Med. 2006;47(3):528\u201333.","journal-title":"J Nucl Med"},{"issue":"4","key":"689_CR74","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1093\/ndt\/14.4.944","volume":"14","author":"CM Jones","year":"1999","unstructured":"Jones CM, Sumeray M, Heys A, Woolfson RG. Pseudo-proteinuria following gelofusine infusion. Nephrol Dial Transplant. 1999;14(4):944\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"689_CR75","doi-asserted-by":"publisher","first-page":"e00985","DOI":"10.1128\/AAC.00985-17","volume":"61","author":"SS Sivanesan","year":"2017","unstructured":"Sivanesan SS, Azad MAK, Schneider EK, Ahmed MU, Huang J, Wang J, et al. Gelofusine ameliorates colistin-induced nephrotoxicity. Antimicrob Agents Chemother. 2017;61(12):e00985-e1017.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"689_CR76","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.3390\/nu11102435","volume":"11","author":"C Rodr\u00edguez-P\u00e9rez","year":"2019","unstructured":"Rodr\u00edguez-P\u00e9rez C, Garc\u00eda-Villanova B, Guerra-Hern\u00e1ndez E, Verardo V. Grape Seeds proanthocyanidins: an overview of in vivo bioactivity in animal models. Nutrients. 2019;11(10):2435.","journal-title":"Nutrients"},{"key":"689_CR77","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.toxrep.2018.04.006","volume":"5","author":"MI Yousef","year":"2018","unstructured":"Yousef MI, Khalil D, Abdou HM. Neuro- and nephroprotective effect of grape seed proanthocyanidin extract against carboplatin and thalidomide through modulation of inflammation, tumor suppressor protein p53, neurotransmitters, oxidative stress and histology. Toxicol Rep. 2018;5:568\u201378.","journal-title":"Toxicol Rep"},{"key":"689_CR78","doi-asserted-by":"crossref","first-page":"5205903","DOI":"10.1155\/2020\/5205903","volume":"2020","author":"Y Ding","year":"2020","unstructured":"Ding Y, Li H, Li Y, Liu D, Zhang L, Wang T, et al. Protective effects of grape seed proanthocyanidins on the kidneys of diabetic rats through the Nrf2 signalling pathway. Evid Based Complement Alternat Med. 2020;2020:5205903.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"8","key":"689_CR79","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1128\/AAC.00343-13","volume":"57","author":"G Ozkan","year":"2013","unstructured":"Ozkan G, Ulusoy S, Orem A, Alkanat M, Mungan S, Yulug E, et al. How does colistin-induced nephropathy develop and can it be treated? Antimicrob Agents Chemother. 2013;57(8):3463\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"689_CR80","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eimc.2011.06.007","volume":"30","author":"L Catala","year":"2012","unstructured":"Catala L, Rius C, Garcia de Olalla P, Nelson JL, Alvarez J, Minguell S, et al. Pandemic A\/H1N1 influenza: transmission of the first cases in Spain. Enferm Infecc Microbiol Clin. 2012;30(2):60\u20133.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"3","key":"689_CR81","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/molecules24030648","volume":"24","author":"M Hajialyani","year":"2019","unstructured":"Hajialyani M, Hosein Farzaei M, Echeverr\u00eda J, Nabavi SM, Uriarte E, Sobarzo-S\u00e1nchez E. Hesperidin as a neuroprotective agent: a review of animal and clinical evidence. Molecules. 2019;24(3):648.","journal-title":"Molecules"},{"issue":"37","key":"689_CR82","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.2174\/0929867324666170718104412","volume":"25","author":"S Tejada","year":"2018","unstructured":"Tejada S, Pinya S, Martorell M, Cap\u00f3 X, Tur JA, Pons A, et al. Potential anti-inflammatory effects of hesperidin from the genus citrus. Curr Med Chem. 2018;25(37):4929\u201345.","journal-title":"Curr Med Chem"},{"issue":"17","key":"689_CR83","first-page":"3290","volume":"41","author":"Pu Peng","year":"2016","unstructured":"Peng Pu. Protection mechanisms of hesperidin on mouse with insulin resistance. Zhongguo Zhong Yao Za Zhi. 2016;41(17):3290\u20135.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"6","key":"689_CR84","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1093\/jn\/133.6.1892","volume":"133","author":"H Chiba","year":"2003","unstructured":"Chiba H, Uehara M, Wu J, Wang X, Masuyama R, Suzuki K, et al. Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr. 2003;133(6):1892\u20137.","journal-title":"J Nutr"},{"issue":"2","key":"689_CR85","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.intimp.2015.02.022","volume":"25","author":"XX Liu","year":"2015","unstructured":"Liu XX, Yu DD, Chen MJ, Sun T, Li G, Huang WJ, et al. Hesperidin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting HMGB1 release. Int Immunopharmacol. 2015;25(2):370\u20136.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"689_CR86","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.phymed.2012.12.001","volume":"20","author":"BD Sahu","year":"2013","unstructured":"Sahu BD, Kuncha M, Sindhura GJ, Sistla R. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine. 2013;20(5):453\u201360.","journal-title":"Phytomedicine"},{"issue":"2","key":"689_CR87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.toxlet.2011.10.023","volume":"208","author":"ST Ahmad","year":"2012","unstructured":"Ahmad ST, Arjumand W, Nafees S, Seth A, Ali N, Rashid S, et al. Hesperidin alleviates acetaminophen induced toxicity in Wistar rats by abrogation of oxidative stress, apoptosis and inflammation. Toxicol Lett. 2012;208(2):149\u201361.","journal-title":"Toxicol Lett"},{"issue":"4","key":"689_CR88","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/10799893.2020.1738483","volume":"40","author":"S Wang","year":"2020","unstructured":"Wang S, He N, Xing H, Sun Y, Ding J, Liu L. Function of hesperidin alleviating inflammation and oxidative stress responses in COPD mice might be related to SIRT1\/PGC-1\u03b1\/NF-\u03baB signaling axis. J Recept Signal Transduct Res. 2020;40(4):388\u201394.","journal-title":"J Recept Signal Transduct Res"},{"issue":"6","key":"689_CR89","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/mnfr.201300830","volume":"58","author":"N Xu","year":"2014","unstructured":"Xu N, Zhang L, Dong J, Zhang X, Chen YG, Bao B, et al. Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. Mol Nutr Food Res. 2014;58(6):1258\u201368.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"689_CR90","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/138955709787001712","volume":"9","author":"M L\u00f3pez-L\u00e1zaro","year":"2009","unstructured":"L\u00f3pez-L\u00e1zaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem. 2009;9(1):31\u201359.","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"689_CR91","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1007\/s11033-020-05346-1","volume":"47","author":"AJA Albarakati","year":"2020","unstructured":"Albarakati AJA, Baty RS, Aljoudi AM, Habotta OA, Elmahallawy EK, Kassab RB, et al. Luteolin protects against lead acetate-induced nephrotoxicity through antioxidant, anti-inflammatory, anti-apoptotic, and Nrf2\/HO-1 signaling pathways. Mol Biol Rep. 2020;47(4):2591\u2013603.","journal-title":"Mol Biol Rep"},{"issue":"4","key":"689_CR92","first-page":"300060520903642","volume":"48","author":"C Xiong","year":"2020","unstructured":"Xiong C, Wu Q, Fang M, Li H, Chen B, Chi T. Protective effects of luteolin on nephrotoxicity induced by long-term hyperglycaemia in rats. J Int Med Res. 2020;48(4):300060520903642.","journal-title":"J Int Med Res"},{"key":"689_CR93","doi-asserted-by":"publisher","first-page":"9783893","DOI":"10.1155\/2017\/9783893","volume":"2017","author":"X Hong","year":"2017","unstructured":"Hong X, Zhao X, Wang G, Zhang Z, Pei H, Liu Z. Luteolin treatment protects against renal ischemia-reperfusion injury in rats. Mediators Inflamm. 2017;2017:9783893.","journal-title":"Mediators Inflamm"},{"issue":"10","key":"689_CR94","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1080\/0886022X.2016.1229995","volume":"38","author":"BY Arslan","year":"2016","unstructured":"Arslan BY, Arslan F, Erkalp K, Alag\u00f6l A, Sevdi MS, Y\u0131ld\u0131z G, et al. Luteolin ameliorates colistin-induced nephrotoxicity in the rat models. Ren Fail. 2016;38(10):1735\u201340.","journal-title":"Ren Fail"},{"key":"689_CR95","doi-asserted-by":"publisher","first-page":"1920208","DOI":"10.1155\/2016\/1920208","volume":"2016","author":"R Szymanska","year":"2016","unstructured":"Szymanska R, Pospisil P, Kruk J. Plant-derived antioxidants in disease prevention. Oxid Med Cell Longev. 2016;2016:1920208.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"689_CR96","doi-asserted-by":"publisher","first-page":"311","DOI":"10.4274\/tjps.43043","volume":"14","author":"M Bacanli","year":"2017","unstructured":"Bacanli M, Ba\u015faran N, Ba\u015faran AA. Lycopene: is it beneficial to human health as an antioxidant? Turk J Pharm Sci. 2017;14(3):311\u20138.","journal-title":"Turk J Pharm Sci"},{"issue":"1","key":"689_CR97","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1128\/AAC.03925-14","volume":"59","author":"C Dai","year":"2015","unstructured":"Dai C, Tang S, Deng S, Zhang S, Zhou Y, Velkov T, et al. Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2\/HO-1 pathway. Antimicrob Agents Chemother. 2015;59(1):579\u201385.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"689_CR98","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2020e10660","volume":"54","author":"F Bedir","year":"2021","unstructured":"Bedir F, Kocaturk H, Turangezli O, Sener E, Akyuz S, Ozgeris FB, et al. The protective effect of lycopene against oxidative kidney damage associated with combined use of isoniazid and rifampicin in rats. Braz J Med Biol Res. 2021;54(8): e10660-e.","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"689_CR99","doi-asserted-by":"publisher","first-page":"e32-e","DOI":"10.34172\/jrip.2020.32","volume":"9","author":"S Haghighipour","year":"2020","unstructured":"Haghighipour S, Soltani R, Anjomshoa A. The protective effect of lycopene supplement against vancomycin-induced nephrotoxicity; a randomized double-blind placebo-controlled clinical trial. J Renal Inj Prev. 2020;9(4):e32-e.","journal-title":"J Renal Inj Prev"},{"issue":"1","key":"689_CR100","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.nefro.2019.06.009","volume":"40","author":"Z Raza","year":"2020","unstructured":"Raza Z, Naureen Z. Melatonin ameliorates the drug induced nephrotoxicity: molecular insights. Nefrologia. 2020;40(1):12\u201325.","journal-title":"Nefrologia"},{"issue":"1","key":"689_CR101","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1177\/2042018813476084","volume":"4","author":"I Kostoglou-Athanassiou","year":"2013","unstructured":"Kostoglou-Athanassiou I. Therapeutic applications of melatonin. Ther Adv Endocrinol Metab. 2013;4(1):13\u201324.","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"107","key":"689_CR102","first-page":"163","volume":"25","author":"Y Dudka","year":"2021","unstructured":"Dudka Y, Zamorskii I, Shchudrova T, Petriuk A, Kopchuk T, Drachuk V. Nephroprotective mechanisms, therapeutic potential and perspective on melatonin use for drug-induced nephropathy. Med Sci. 2021;25(107):163\u20139.","journal-title":"Med Sci"},{"issue":"9","key":"689_CR103","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1128\/AAC.00328-11","volume":"55","author":"JM Yousef","year":"2011","unstructured":"Yousef JM, Chen G, Hill PA, Nation RL, Li J. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother. 2011;55(9):4044\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"689_CR104","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/antiox8050111","volume":"8","author":"\u0160 \u0160alamon","year":"2019","unstructured":"\u0160alamon \u0160, Kramar B, Marolt TP, Polj\u0161ak B, Milisav I. Medical and dietary uses of N-acetylcysteine. Antioxidants (Basel). 2019;8(5):111.","journal-title":"Antioxidants (Basel)"},{"key":"689_CR105","doi-asserted-by":"publisher","first-page":"9949453","DOI":"10.1155\/2021\/9949453","volume":"2021","author":"GK Schwalfenberg","year":"2021","unstructured":"Schwalfenberg GK. N-acetylcysteine: a review of clinical usefulness (an old drug with new tricks). J Nutr Metab. 2021;2021:9949453.","journal-title":"J Nutr Metab"},{"issue":"1","key":"689_CR106","doi-asserted-by":"publisher","first-page":"e55124-e","DOI":"10.1371\/journal.pone.0055124","volume":"8","author":"Z Sun","year":"2013","unstructured":"Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z. Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS ONE. 2013;8(1):e55124-e.","journal-title":"PLoS ONE"},{"key":"689_CR107","first-page":"4805853","volume":"2019","author":"S Huang","year":"2019","unstructured":"Huang S, You J, Wang K, Li Y, Zhang Y, Wei H, et al. N-acetylcysteine attenuates cisplatin-induced acute kidney injury by inhibiting the C5a receptor. BioMed Res Int. 2019;2019:4805853.","journal-title":"BioMed Res Int"},{"issue":"7","key":"689_CR108","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/bjp.2008.15","volume":"153","author":"N Chen","year":"2008","unstructured":"Chen N, Aleksa K, Woodland C, Rieder M, Koren G. N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol. 2008;153(7):1364\u201372.","journal-title":"Br J Pharmacol"},{"issue":"26","key":"689_CR109","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1056\/NEJMoa054209","volume":"354","author":"G Marenzi","year":"2006","unstructured":"Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med. 2006;354(26):2773\u201382.","journal-title":"N Engl J Med"},{"issue":"1","key":"689_CR110","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00134-010-2038-7","volume":"37","author":"E Ozyilmaz","year":"2011","unstructured":"Ozyilmaz E, Ebinc FA, Derici U, Gulbahar O, Goktas G, Elmas C, et al. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med. 2011;37(1):141\u20136.","journal-title":"Intensive Care Med"},{"issue":"1","key":"689_CR111","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/0886022X.2018.1489286","volume":"40","author":"B Ceylan","year":"2018","unstructured":"Ceylan B, Ozansoy M, K\u0131l\u0131\u00e7 \u00dc, Yozgat Y, Ercan \u00c7, Y\u0131ld\u0131z P, et al. N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions. Ren Fail. 2018;40(1):423\u201334.","journal-title":"Ren Fail"},{"issue":"49","key":"689_CR112","doi-asserted-by":"publisher","first-page":"e9061-e","DOI":"10.1097\/MD.0000000000009061","volume":"96","author":"S Zhong","year":"2017","unstructured":"Zhong S, Fan Y, Yan Q, Fan X, Wu B, Han Y, et al. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: a meta-analysis (PRISMA) of randomized control trials. Medicine. 2017;96(49):e9061-e.","journal-title":"Medicine"},{"issue":"4","key":"689_CR113","first-page":"308","volume":"14","author":"G Karimi","year":"2011","unstructured":"Karimi G, Vahabzadeh M, Lari P, Rashedinia M, Moshiri M. \u201cSilymarin\u201d, a promising pharmacological agent for treatment of diseases. Iran J Basic Med Sci. 2011;14(4):308\u201317.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"689_CR114","doi-asserted-by":"publisher","first-page":"112","DOI":"10.18433\/J3F88S","volume":"15","author":"S Dashti-Khavidaki","year":"2012","unstructured":"Dashti-Khavidaki S, Shahbazi F, Khalili H, Lessan-Pezeshki M. Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature. J Pharm Pharm Sci. 2012;15(1):112\u201323.","journal-title":"J Pharm Pharm Sci"},{"issue":"6","key":"689_CR115","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1080\/01480545.2019.1584208","volume":"43","author":"S Guzel","year":"2020","unstructured":"Guzel S, Sahinogullari ZU, Canacankatan N, Antmen SE, Kibar D, Coskun YB. Potential renoprotective effects of silymarin against vancomycin-induced nephrotoxicity in rats. Drug Chem Toxicol. 2020;43(6):630\u20136.","journal-title":"Drug Chem Toxicol"},{"key":"689_CR116","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/2008-7802.174762","volume":"7","author":"Z Sedighifard","year":"2016","unstructured":"Sedighifard Z, Roghani F, Bidram P, Harandi SA, Molavi S. Silymarin for the prevention of contrast-induced nephropathy: a placebo-controlled clinical trial. Int J Prev Med. 2016;7:23.","journal-title":"Int J Prev Med"},{"issue":"5","key":"689_CR117","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1002\/nau.23109","volume":"36","author":"SMS Hassan","year":"2017","unstructured":"Hassan SMS, Youakim MF, Rizk AAE, Thomann C, Ahmad Z. Does silybin protect against toxicity induced by polymyxin E in rat kidney? Neurourol Urodyn. 2017;36(5):1278\u201387.","journal-title":"Neurourol Urodyn"},{"issue":"8","key":"689_CR118","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/nau.23249","volume":"36","author":"SS Hassan","year":"2017","unstructured":"Hassan SS, Thomann C, Ettarh R, Ahmad Z. Possible protective role of silybin against polymyxin E-induced toxic effect in rat kidneys: a biochemical approach. Neurourol Urodyn. 2017;36(8):2003\u201310.","journal-title":"Neurourol Urodyn"},{"key":"689_CR119","doi-asserted-by":"publisher","DOI":"10.1080\/01480545.2020.1733003","author":"B Dumludag","year":"2020","unstructured":"Dumludag B, Derici MK, Sutcuoglu O, Ogut B, Pasaoglu OT, Gonul II, et al. Role of silymarin (Silybum marianum) in the prevention of colistin-induced acute nephrotoxicity in rats. Drug Chem Toxicol. 2020. https:\/\/doi.org\/10.1080\/01480545.2020.1733003.","journal-title":"Drug Chem Toxicol"},{"key":"689_CR120","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/978-1-4615-0077-3_39","volume":"526","author":"S Schaffer","year":"2003","unstructured":"Schaffer S, Azuma J, Takahashi K, Mozaffari M. Why is taurine cytoprotective? Adv Exp Med Biol. 2003;526:307\u201321.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"689_CR121","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4062\/biomolther.2017.251","volume":"26","author":"S Schaffer","year":"2018","unstructured":"Schaffer S, Kim HW. Effects and mechanisms of taurine as a therapeutic agent. Biomol Ther (Seoul). 2018;26(3):225\u201341.","journal-title":"Biomol Ther (Seoul)"},{"issue":"2","key":"689_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mi.2021.3","volume":"1","author":"S Baliou","year":"2021","unstructured":"Baliou S, Adamaki M, Ioannou P, Pappa A, Panayiotidis MI, Christodoulou I, et al. Ameliorative effect of taurine against diabetes and renal-associated disorders. Med Int. 2021;1(2):1\u201319.","journal-title":"Med Int"},{"key":"689_CR123","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.biopha.2018.10.093","volume":"109","author":"R Heidari","year":"2019","unstructured":"Heidari R, Behnamrad S, Khodami Z, Ommati MM, Azarpira N, Vazin A. The nephroprotective properties of taurine in colistin-treated mice is mediated through the regulation of mitochondrial function and mitigation of oxidative stress. Biomed Pharmacother. 2019;109:103\u201311.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"689_CR124","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1046\/j.1523-5408.2002.00005.x","volume":"5","author":"RA Jacob","year":"2002","unstructured":"Jacob RA, Sotoudeh G. Vitamin C function and status in chronic disease. Nutr Clin Care. 2002;5(2):66\u201374.","journal-title":"Nutr Clin Care"},{"key":"689_CR125","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2741\/4160","volume":"18","author":"G Grosso","year":"2013","unstructured":"Grosso G, Bei R, Mistretta A, Marventano S, Calabrese G, Masuelli L, et al. Effects of vitamin C on health: a review of evidence. Front Biosci (Landmark edition). 2013;18:1017\u201329.","journal-title":"Front Biosci (Landmark edition)"},{"issue":"1","key":"689_CR126","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/2314808X.2019.1707626","volume":"7","author":"S Rastogi","year":"2020","unstructured":"Rastogi S, Gupta S, Haldar C, Chandra D. Nephroprotective effect of melatonin and L-ascorbic acid (Vitamin-C) against ampicillin- induced toxicity in Funambulus pennanti. Egypt J Basic Appl Sci. 2020;7(1):8\u201319.","journal-title":"Egypt J Basic Appl Sci"},{"issue":"9","key":"689_CR127","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.3346\/jkms.2017.32.9.1468","volume":"32","author":"MH Cho","year":"2017","unstructured":"Cho MH, Kim SN, Park HW, Chung S, Kim KS. Could vitamin E prevent contrast-induced acute kidney injury? A systematic review and meta-analysis. J Korean Med Sci. 2017;32(9):1468\u201373.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"689_CR128","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jac\/dkr483","volume":"67","author":"JM Yousef","year":"2012","unstructured":"Yousef JM, Chen G, Hill PA, Nation RL, Li J. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother. 2012;67(2):452\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"689_CR129","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1128\/AAC.00280-15","volume":"59","author":"R Sirijatuphat","year":"2015","unstructured":"Sirijatuphat R, Limmahakhun S, Sirivatanauksorn V, Nation RL, Li J, Thamlikitkul V. Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity. Antimicrob Agents Chemother. 2015;59(6):3224\u201332.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"689_CR130","first-page":"e157","volume":"14","author":"S Rizvi","year":"2014","unstructured":"Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The role of vitamin e in human health and some diseases. Sultan Qaboos Univ Med J. 2014;14(2):e157\u201365.","journal-title":"Sultan Qaboos Univ Med J"},{"key":"689_CR131","doi-asserted-by":"publisher","first-page":"9961","DOI":"10.2147\/IJN.S276355","volume":"15","author":"AS Mohd Zaffarin","year":"2020","unstructured":"Mohd Zaffarin AS, Ng SF, Ng MH, Hassan H, Alias E. Pharmacology and pharmacokinetics of vitamin E: nanoformulations to enhance bioavailability. Int J Nanomed. 2020;15:9961\u201374.","journal-title":"Int J Nanomed"},{"issue":"Suppl 1","key":"689_CR132","doi-asserted-by":"publisher","first-page":"S2133","DOI":"10.3233\/BME-151519","volume":"26","author":"P Liu","year":"2015","unstructured":"Liu P, Feng Y, Wang Y, Zhou Y, Zhao L. Protective effect of vitamin E against acute kidney injury. Bio-Med Mater Eng. 2015;26(Suppl 1):S2133\u201344.","journal-title":"Bio-Med Mater Eng"},{"issue":"1","key":"689_CR133","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/1319-2442.225205","volume":"29","author":"Z Ghlissi","year":"2018","unstructured":"Ghlissi Z, Hakim A, Mnif H, Kallel R, Zeghal K, Boudawara T, et al. Effect of vitamin E on reversibility of renal function following discontinuation of colistin in rats: histological and biochemical investigations. Saudi J Kidney Dis Transpl. 2018;29(1):10\u20138.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"689_CR134","doi-asserted-by":"publisher","first-page":"545","DOI":"10.4103\/1319-2442.235168","volume":"29","author":"Z Ghlissi","year":"2018","unstructured":"Ghlissi Z, Hakim A, Mnif H, Zeghal K, Rebai T, Boudawara T, et al. Combined use of vitamins E and C improve nephrotoxicity induced by colistin in rats. Saudi J Kidney Dis Transpl. 2018;29(3):545\u201353.","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"2","key":"689_CR135","first-page":"180","volume":"66","author":"Z Bader","year":"2016","unstructured":"Bader Z, Waheed A, Hashim R. Establishment and comparison of nephrotoxicity associated with the use of various doses of conlistin in rabbits. Pak Armed Forces Med J. 2016;66(2):180\u20134.","journal-title":"Pak Armed Forces Med J"},{"issue":"2","key":"689_CR136","first-page":"463","volume":"31","author":"Z Bader","year":"2018","unstructured":"Bader Z, Waheed A, Bakhtiar S, Khan IM. Alpha-tocopherol ameliorates nephrotoxicity associated with the use of colistin in rabbits. Pak J Pharm Sci. 2018;31(2):463\u20137.","journal-title":"Pak J Pharm Sci"},{"key":"689_CR137","doi-asserted-by":"publisher","DOI":"10.15761\/CMID.1000161","author":"O Moradi","year":"2019","unstructured":"Moradi O, Sahraei Z, Asadi S. From bench to bedside: colistin nephrotoxicity and vitamin. Clin Microbiol Infect Dis. 2019. https:\/\/doi.org\/10.15761\/CMID.1000161.","journal-title":"Clin Microbiol Infect Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00689-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00689-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T01:36:19Z","timestamp":1727141779000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00689-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["689"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00689-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"20 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}